The US FDA has issued a warning letter to Zydus Lifesciences citing significant manufacturing lapses at its Gujarat-based plant.
The NIFTY 50 index is exhibiting a bullish trend on the charts, making it an attractive option for traders seeking to capitalise on the ongoing upward momentum.
Recently, IRCTC's stock price has been consolidating around its 200-day Exponential Moving Average (DEMA), which is often seen as a critical support level.
For over 8 months, CEAT has faced resistance around the 2,900 level. However, prices have now broken this range, confirming a strong 'Inverse Head and Shoulders' breakout
Details of the offering such as size and timing are still under discussion and subject to change, they said
Foreign portfolio investors made an unexpected move into Indian equities last week, injecting over $2 billion
Also, a series of regulatory reforms aimed at streamlining the process for FPI investments has further uplifted investor sentiment
He says that a 25-bp cut with a strong dovish message could be as effective as a 50-bp cut with minimal commentary
LTCG tax perks and bond drought create perfect storm
As of June 2024, the fund's assets under management totalled Rs 56,469 crore, up from Rs 15,353 crore in June 2021